- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Surgery Partners Inc (SGRY)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/06/2026: SGRY (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $25.45
1 Year Target Price $25.45
| 8 | Strong Buy |
| 1 | Buy |
| 3 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -45.78% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.98B USD | Price to earnings Ratio - | 1Y Target Price 25.45 |
Price to earnings Ratio - | 1Y Target Price 25.45 | ||
Volume (30-day avg) 12 | Beta 1.91 | 52 Weeks Range 14.94 - 26.16 | Updated Date 01/6/2026 |
52 Weeks Range 14.94 - 26.16 | Updated Date 01/6/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.36 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -5.21% | Operating Margin (TTM) 16.45% |
Management Effectiveness
Return on Assets (TTM) 4.19% | Return on Equity (TTM) 0.66% |
Valuation
Trailing PE - | Forward PE 17.99 | Enterprise Value 5641555547 | Price to Sales(TTM) 0.6 |
Enterprise Value 5641555547 | Price to Sales(TTM) 0.6 | ||
Enterprise Value to Revenue 1.72 | Enterprise Value to EBITDA 10.14 | Shares Outstanding 129341779 | Shares Floating 55658243 |
Shares Outstanding 129341779 | Shares Floating 55658243 | ||
Percent Insiders 1.43 | Percent Institutions 119.39 |
Upturn AI SWOT
Surgery Partners Inc

Company Overview
History and Background
Surgery Partners Inc. was founded in 2004. It has evolved into a leading national owner and operator of surgical facilities and a provider of outsourced administrative and specialized services to physicians and surgical facilities. Key milestones include its IPO in 2015 and subsequent strategic acquisitions to expand its geographic footprint and service offerings.
Core Business Areas
- Surgical Facility Operations: The company owns and operates a network of ambulatory surgery centers (ASCs) and surgical hospitals. These facilities provide a wide range of surgical procedures, focusing on outpatient settings that are typically more cost-effective and convenient for patients than inpatient hospital stays.
- Ancillary Services: Surgery Partners offers a suite of ancillary services to support its surgical facilities and physicians. This includes revenue cycle management, laboratory services, and patient advocacy services.
- Physician Services: The company partners with physicians to develop, acquire, and manage surgical facilities, providing them with operational and administrative support to enhance their practices.
Leadership and Structure
Surgery Partners Inc. is led by a management team with extensive experience in the healthcare industry. The company operates through a decentralized model, with facility-level management teams reporting to regional and corporate leadership. The exact structure is subject to change as the company grows and integrates acquisitions.
Top Products and Market Share
Key Offerings
- Ambulatory Surgery Centers (ASCs): The core offering is access to its network of ASCs, which provide a platform for physicians to perform a wide array of elective surgical procedures across various specialties. Market share data for individual ASCs is highly fragmented and location-specific. Competitors include other ASC management companies, physician-owned facilities, and hospital-affiliated outpatient surgical services.
- Surgical Hospitals: Similar to ASCs but offering a broader range of services and potentially longer patient stays, these facilities cater to more complex procedures. Market share is difficult to pinpoint as it's often embedded within broader hospital system data. Competitors include general hospitals and specialized surgical hospitals.
- Revenue Cycle Management Services: These services help healthcare providers manage billing, claims processing, and collections to optimize financial performance. This is a service offering rather than a direct patient product. Competitors include specialized revenue cycle management companies and in-house billing departments.
Market Dynamics
Industry Overview
The ambulatory surgery center market is a growing segment within the healthcare industry. Key drivers include an aging population requiring more surgical interventions, a shift towards less invasive procedures, a preference for outpatient settings due to cost and convenience, and favorable reimbursement policies for ASCs compared to traditional hospitals. The industry faces challenges related to regulatory changes, physician alignment, and competition.
Positioning
Surgery Partners is positioned as a leading consolidator and operator in the fragmented ASC market. Its strategy of acquiring and developing facilities, partnering with physicians, and offering integrated services provides a competitive advantage through scale, operational efficiency, and a diversified revenue model. They compete by offering physicians attractive partnership opportunities and patients high-quality, cost-effective surgical care.
Total Addressable Market (TAM)
The total addressable market for ambulatory surgery centers is substantial and growing. While precise figures vary, estimates suggest the US ASC market is valued in the tens of billions of dollars annually and is projected to continue its upward trajectory. Surgery Partners, as a significant operator, aims to capture a larger share of this market through strategic growth and operational excellence.
Upturn SWOT Analysis
Strengths
- Extensive network of surgical facilities across multiple states.
- Experienced management team with deep healthcare operational expertise.
- Diversified service offerings beyond core surgical procedures.
- Strong physician relationships and partnership models.
- Ability to benefit from economies of scale and operational efficiencies.
Weaknesses
- Reliance on physician partnerships, which can be complex.
- Potential for integration challenges with acquired entities.
- Vulnerability to changes in healthcare regulations and reimbursement policies.
- Geographic concentration in certain regions may limit broader market penetration.
Opportunities
- Continued consolidation in the fragmented ASC market through strategic acquisitions.
- Expansion into new geographic markets and surgical specialties.
- Leveraging technology to improve patient experience and operational efficiency.
- Growing demand for outpatient procedures due to an aging population.
- Partnerships with health insurance providers to offer value-based care models.
Threats
- Increased competition from hospital systems expanding their outpatient services.
- Changes in government reimbursement policies (e.g., Medicare, Medicaid).
- Potential for increased scrutiny and regulation of ASCs.
- Economic downturns affecting elective procedure volumes.
- Physician burnout and changing practice patterns.
Competitors and Market Share
Key Competitors
- Envision Healthcare Corporation (EVHC - no longer publicly traded)
- HCA Healthcare, Inc. (HCA)
- Select Medical Holdings Corporation (SEM)
- Tenet Healthcare Corporation (THC)
Competitive Landscape
Surgery Partners holds a significant position in the ASC market, but faces intense competition. HCA Healthcare and Tenet Healthcare are large, diversified healthcare systems with substantial outpatient surgical operations. Select Medical Holdings specializes in post-acute care but also operates surgical facilities. The competitive advantage for Surgery Partners lies in its focused strategy on ASCs, strong physician partnerships, and efficient operational model. However, competitors often benefit from greater scale, brand recognition, and broader service lines.
Major Acquisitions
American Anesthesiology Associates, LLC
- Year: 2017
- Acquisition Price (USD millions):
- Strategic Rationale: This acquisition aimed to enhance Surgery Partners' service offerings by integrating a leading anesthesia services provider, allowing for a more comprehensive suite of solutions for its surgical facilities and physicians.
Various Smaller ASC Groups and Facilities
- Year: Ongoing
- Acquisition Price (USD millions): Varies
- Strategic Rationale: Continuous stream of acquisitions to expand geographic reach, increase the number of surgical facilities, add new specialties, and gain market share through consolidation.
Growth Trajectory and Initiatives
Historical Growth: Surgery Partners has experienced significant historical growth, largely through a strategy of acquiring and integrating other surgical facilities and companies. This has led to an expanding footprint and increased revenue. Organic growth from existing facilities has also contributed.
Future Projections: Future growth is projected to continue through a combination of strategic acquisitions, de novo facility development, and same-store growth initiatives. Analysts often provide projections for revenue and adjusted EBITDA growth, taking into account market trends and the company's pipeline. For instance, projections might indicate a 5-10% annual revenue growth rate.
Recent Initiatives: Recent initiatives likely include further acquisitions to consolidate market share, investments in technology to enhance patient care and operational efficiency, and programs to optimize reimbursement and cost management across its network of facilities.
Summary
Surgery Partners Inc. is a well-established operator in the growing ambulatory surgery center market, leveraging strategic acquisitions and strong physician partnerships for growth. Its diversified service offerings and operational efficiencies are key strengths. However, the company faces significant competition and regulatory risks inherent in the healthcare sector. Continued focus on integration, market expansion, and adapting to evolving healthcare policies will be crucial for sustained success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Investor Relations Filings (SEC)
- Financial News and Data Providers (e.g., Bloomberg, Refinitiv, Yahoo Finance)
- Industry Research Reports
Disclaimers:
This JSON output is for informational purposes only and does not constitute investment advice. Financial data and market share percentages are illustrative and subject to change. Actual financial performance and market positions may vary. Users should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Surgery Partners Inc
Exchange NASDAQ | Headquaters Brentwood, TN, United States | ||
IPO Launch date 2015-10-01 | CEO & Director Mr. J. Eric Evans | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 15000 | Website https://www.surgerypartners.com |
Full time employees 15000 | Website https://www.surgerypartners.com | ||
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

